Matthew W. Foehr - 11 Apr 2025 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
11 Apr 2025
Net transactions value
+$166,288
Form type
4
Filing time
14 Apr 2025, 19:26:34 UTC
Previous filing
07 Apr 2025
Next filing
26 Aug 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $166,288 +20,786 +19% $8.00 132,036 11 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -20,786 -100% $0.000000 0 11 Apr 2025 Common Stock 20,786 $8.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.